AGREEMENT FOR MODIFICATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISES
Exhibit 10.1
AGREEMENT FOR MODIFICATION OF LEASE
AND VOLUNTARY SURRENDER OF PREMISES
This Agreement for Modification of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of September 20, 2023 (the “Effective Date”), by and between ARE-SAN FRANCISCO NO. 63, LLC, a Delaware limited liability company (“Landlord”), and ATRECA, INC., a Delaware corporation (“Tenant”), with reference to the following:
RECITALS
X. Xxxxxxxx to that certain Lease Agreement dated as of July 17, 2019 (the “Original Lease”), as amended by that certain letter agreement dated as of August 24, 2020 (as amended, the “Lease”), Tenant leases from Landlord certain premises containing approximately 99,557 rentable square feet (the “Premises”) in that certain building located at 000 Xxxxxxxxxx Xxxx, Xxx Xxxxxx, Xxxxxxxxxx, as more particularly described in the Lease. Capitalized terms used herein without definition shall have the meanings defined for such terms in the Lease.
B. The Term of the Lease is scheduled to expire on April 30, 2033 (the “Scheduled Expiration Date”).
X. Xxxxxx and Landlord desire, subject to the terms and conditions set forth below, to accelerate the expiration date of the Term of the Lease.
NOW, THEREFORE, in consideration of the foregoing Recitals, which are incorporated herein by this reference, the mutual promises and conditions contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows:
1. Modification of Lease. Landlord and Xxxxxx hereby agree as follows:
a. | The Scheduled Expiration Date shall be accelerated to the date (as applicable, the “Termination Date”) that is the earlier of (i) April 30, 2024 (the “Outside Termination Date”), and (ii) such earlier date that Landlord elects to terminate the Lease after the Early Vacate Date (as defined below), pursuant to the Accelerated Termination Right (as defined below) with respect to all or any portion of the Premises. |
b. | Notwithstanding anything to the contrary contained in this Agreement, Landlord shall have the right (“Accelerated Termination Right”) any time during the Option Period (as defined below), by delivery of not less than 2 business days’ advance written notice to Tenant (“Accelerated Termination Notice”), to further accelerate the Termination Date with respect to all or any portion of the Premises to a date prior to the Outside Termination Date, whereupon the term of the Lease shall automatically terminate on the date specified in such Accelerated Termination Notice (which shall in no event be earlier than the date that is 2 business days after Landlord’s delivery to Tenant of the Accelerated Termination Notice). |
c. | From and after the Termination Date, Tenant’s Re-Occupancy Right (as defined below) with respect to the Premises shall automatically lapse. |
d. | Notwithstanding anything to the contrary contained in the Lease or this Agreement, to the extent that Landlord has not exercised the Accelerated Termination Right, Tenant shall have the option to elect to vacate the Premises any time during the period commencing on November 30, 2023 (the “Option Period Commencement Date”), through the day immediately preceding the Outside Termination Date (the “Option Period”). Landlord and Xxxxxx acknowledge and agree that Xxxxxx elected to vacate the Premises as of 11:59 PM Pacific time on November 30, 2023 (the “Early Vacate Date”). |
1 |
e. | If Tenant vacates the Premises on the Early Vacate Date in accordance with the terms of Section 2 below, then so long as Tenant does not elect to exercise its Re-Occupancy Right, Tenant shall not be required to pay any Base Rent, Operating Expenses, Additional Tenant Improvement Allowance or any other recurring monthly financial obligations arising under the Lease, for the period commencing on the Early Vacate Date through the Termination Date. |
f. | If, notwithstanding Xxxxxx’s election above with respect to the Early Vacate Date, Tenant does not vacate the Premises by the Early Vacate Date, then from and after the Early Vacate Date through the Termination Date, Tenant shall pay Base Rent, Operating Expenses and all other obligations of Tenant under the Lease with respect to the Premises. |
2. Option to Early Vacate. Landlord and Tenant hereby agree, subject to Tenant’s satisfaction (or Landlord’s waiver) of all of the terms and conditions set forth in this Agreement and subject to Tenant’s Re-Occupancy Right (defined below), that (a) Tenant shall, on the Early Vacate Date, voluntarily quit and vacate the Premises in the condition required by the Lease; provided, however, Tenant shall not have any removal or restoration obligations with respect to any Installations, cabling/wiring or signage, (b) commencing on the Early Vacate Date, and so long as Tenant does not elect to exercise its Re-Occupancy Right, Tenant shall have no right to enter, use, sublease or occupy the Premises, (c) commencing on the Early Vacate Date and continuing through and until the Termination Date, Tenant agrees to cooperate with Landlord, which cooperation shall include, without limitation, Tenant’s provision to Landlord and Landlord’s employees, agents, contractors and invitees (each, a “Landlord Party”), full access to the Premises (“Landlord’s Access Right”), without cost, expense or liability to Tenant, (d) Tenant hereby waives any and all claims against Landlord and any other Landlord Party in connection with the exercise of Landlord’s Access Right (including, without limitation, any claim for rent abatement) except to the extent caused by Landlord’s or any Landlord Party’s willful misconduct or negligence, and (e) all other terms and conditions contained within the Lease regarding surrender and vacating the Premises shall remain in full force and effect.
3. Landlord Alteration Work. From and after the Early Vacate Date and continuing through and until the Termination Date, Landlord shall have the option to undertake construction and/or alterations with respect to the Premises (the “Landlord Alteration Work”), and Landlord’s Access Right shall include the right to access the Premises to perform such Landlord Alteration Work (“Landlord’s Alteration Right”). Notwithstanding anything to the contrary contained in the Lease (as amended hereby), any Landlord Alteration Work shall be without cost, expense or liability to Tenant (except to the extent such cost, expense or liability is caused by Tenant or any Tenant Parties). Notwithstanding the foregoing, if Tenant has exercised its Re-Occupancy Right with respect to the Premises, Landlord’s right to continue to access the Premises pursuant to Landlord’s Access Right and perform the Landlord Alteration Work shall terminate effective as of the Re-Occupancy Date.
4. Lease Modification Payment. In consideration of Landlord’s agreement to enter into this Agreement, Tenant shall pay to Landlord an amount equal to $5,115,038.40 (the “Lease Modification Payment”). The Lease Modification Payment shall be paid as follows:
a. | Letter of Credit Draw. Landlord shall have the right to draw down the full amount of the letter of credit that Landlord is holding pursuant to Section 6 of the Original Lease in the amount of $1,115,038.40 (the “Letter of Credit”) and retain the funds on or after the Effective Date, and |
2 |
b. | Payment. Tenant shall deliver the remainder of the Lease Modification Payment in cash in the amount of $4,000,000.00 to Landlord concurrent with Xxxxxx’s delivery to Landlord of a copy of this Agreement signed by Xxxxxx. |
Tenant shall cooperate in all respects with Landlord to enable Landlord to draw the full amount of the Letter of Credit, including, without limitation, providing written authorization to the bank holding the Letter of Credit to process Landlord’s draw request. Notwithstanding anything to the contrary contained in this Agreement, if Xxxxxx does not surrender the Premises on or before the Termination Date in strict accordance with the terms of this Agreement, the Term of the Lease shall nonetheless terminate on the Termination Date and the holdover provisions of the Lease shall apply. Notwithstanding anything to the contrary contained in the Lease, Tenant shall have no further right to extend the Term of the Lease, and the Term of the Lease shall terminate on the Termination Date.
5. Base Rent and Operating Expenses. Subject to Section 1(e) above, Tenant shall be responsible for the payment of all Base Rent, Operating Expenses and any other obligations due under the Lease through the Termination Date. Tenant shall not be required to pay Base Rent, Operating Expenses or any other recurring monthly financial obligations arising under the Lease for any period following the Termination Date so long as Tenant surrenders the Premises in strict compliance with this Agreement and the Lease (as modified herein), and Tenant is not in breach hereof or under the Lease.
6. Termination and Surrender. Tenant shall voluntarily surrender the Premises as provided in this Agreement. Xxxxxx agrees to cooperate reasonably with Landlord in all matters, as applicable, relating to surrendering the Premises in accordance with the surrender requirements set forth in this Agreement and the Lease and in the condition required pursuant to the Lease as modified herein. After the Termination Date, Tenant shall have no further rights of any kind with respect to the Premises. Notwithstanding the foregoing, as provided in Section 8 hereof and subject to the terms hereof, those provisions of the Lease which, by their terms, survive the termination of the Lease shall survive the surrender of the Premises and termination of the Lease provided for herein.
7. Tenant’s Re-Occupancy Right. If Tenant has elected to vacate the Premises and vacated the Premises in accordance with this Agreement, then, any time following the Early Vacate Date and prior to the Termination Date, Tenant may, upon 15 days’ prior written notice to Landlord (such notice, the “Re-Occupancy Notice”), elect to re-occupy all or any portion of the Premises, with such re-occupancy commencing on the date set forth in the Re-Occupancy Notice (the “Re-Occupancy Date”) and continuing through and until the Termination Date (such option, the “Re-Occupancy Right”). In the event that Tenant elects to exercise its Re-Occupancy Right pursuant to this Section 7, Tenant acknowledges and agrees that the following shall apply and shall be conditions thereto:
a. Tenant shall accept the Premises in its then-current “AS IS” condition on the Re-Occupancy Date, which Tenant acknowledges may be a condition different than the condition of the Premises that existed as of the Early Vacate Date;
b. Concurrently with Xxxxxx’s delivery of the Re-Occupancy Notice and notwithstanding Tenant’s payment of the Lease Modification Payment to Landlord and Landlord’s application of the Security Deposit as provided in Section 4(a) above, Tenant shall deliver funds to Landlord equal to the amount of Base Rent and Operating Expenses and all other amounts that would have been payable under the Lease for the Premises for the period commencing on December 1, 2023 through the Re-Occupancy Date but for the abatement provided for in Section 1(e) above;
c. Tenant shall be deemed to have waived any and all claims against Landlord and any other Landlord Party in connection with any exercise of Landlord’s Access Right, Xxxxxxxx’s Alteration Right and any construction or alterations made in connection therewith (including, without limitation, any claim for rent abatement). Following Tenant’s exercise of its Re-Occupancy Right, Landlord’s Access Right under this Agreement shall terminate as of the Re-Occupancy Date; and
d. Tenant’s re-occupancy of the Premises shall be subject to all of the terms and conditions of the Lease (as amended hereby), including, without limitation, the Accelerated Termination Right and Tenant’s obligation to pay Base Rent, Operating Expenses and any other obligations of Tenant under the Lease with respect to the Premises through the Outside Termination Date.
3 |
8. No Further Obligations. Subject to the provisions of Section 2 above, Landlord and Tenant each agree that the other is excused following the Termination Date from any further obligations under the Lease with respect to the Premises, excepting only such obligations under the Lease which are, by their terms, intended to survive termination of the Lease, except that Landlord and Tenant acknowledge and agree that there shall be no further reconciliation of Operating Expenses under the Lease. In addition, nothing herein shall be deemed to limit or terminate any common law or statutory rights Landlord may have with respect to Tenant in connection with any hazardous materials or for violations of any governmental requirements or requirements of applicable law. Nothing herein shall excuse Tenant from its obligations under the Lease, as modified by this Agreement, prior to the Termination Date.
9. Personal Property. Landlord and Tenant hereby agree that, as consideration for entering into this Agreement, Tenant shall transfer certain furniture, fixtures and equipment to Landlord pursuant to a Bill of Sale and Assignment in the form attached hereto as Exhibit A. Subject to the immediately prior sentence, any personal property of Tenant remaining in the Premises after the Termination Date is hereby agreed to be abandoned by Xxxxxx and may be disposed of by Landlord, in Landlord’s sole discretion, without obligation or liability of any kind to Tenant.
10. Tenant’s Notice Address. Any notice given by Landlord to Tenant following the Termination Date may be delivered by (i) reputable overnight courier, or (ii) hand delivery with signature confirming receipt to the following address:
Atreca, Inc.
c/x Xxxxxx LLP
00000 Xxxxxxx Xxxxx, Xxxxx 0000
Xxxxxx, Xxxxxxxx 20190
Attention: Xxxx X. Xxxxxx, Esq.
As a courtesy only, Landlord shall endeavor to email notices to the email addresses below, but Xxxxxxxx’s failure to email such notices shall in no event constitute a default by Landlord or a failure by Landlord to deliver the applicable notice to Tenant:
Xxxx Xxxxxx - xxxxxxx@xxxxxx.xxx
Xxxxxxxx Xxxxxxxx - xxxxxxxxx@xxxxxx.xxx
11. Acknowledgment. Tenant acknowledges that it has read the provisions of this Agreement, understands them, and is bound by them. Time is of the essence in this Agreement.
12. No Assignment. Tenant represents and warrants that Xxxxxx has not assigned, mortgaged, subleased, pledged, encumbered or otherwise transferred any interest in the Lease and that Tenant holds the interest in the Premises as set forth in the Lease as of the date of this Agreement.
13. No Modification. This Agreement may not be modified or terminated except in writing signed by all parties.
14. Successors and Assigns. The covenants and agreements herein contained shall inure to the benefit and be binding upon the parties and their respective successors and assigns.
4 |
15. Attorneys’ Fees. In the event of a dispute between the parties, the prevailing party shall be entitled to have its reasonable attorneys’ fees and costs paid by the other party. Each party shall be responsible for its own costs and legal fees in connection with the negotiation, execution and delivery of this Agreement and the consummation of the transactions contemplated hereby.
16. Reimbursement of Landlord’s Fees. Tenant shall reimburse Landlord for the reasonable out-of-pocket costs incurred by Landlord in connection with preparation and negotiation of this Agreement within 30 days after Xxxxxx’s receipt of an invoice therefor from Landlord.
17. Choice of Law. Construction and interpretation of this Agreement shall be governed by the internal laws of the state in which the Premises are located, excluding any principles of conflicts of laws.
18. Opportunity for Consultation. Each party represents and warrants that such party is entering into this Agreement knowingly and voluntarily and that each party has, or has had the opportunity to, review any and all aspects of this Agreement with the legal, tax or other advisor or advisors of such party’s choice prior to executing this Agreement. Each of the parties has had the opportunity to negotiate the terms, conditions and language of this Agreement. The rule of construction that ambiguities are resolved against the drafting party shall not be applied in interpreting this Agreement.
19. OFAC. Tenant and all beneficial owners of Tenant are currently (a) in compliance with and shall at all times during the Term of the Lease remain in compliance with the regulations of the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of Treasury and any statute, executive order, or regulation relating thereto (collectively, the “OFAC Rules”), (b) not listed on, and shall not during the term of the Lease be listed on, the Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List or the Sectoral Sanctions Identifications List, which are all maintained by OFAC and/or on any other similar list maintained by OFAC or other governmental authority pursuant to any authorizing statute, executive order, or regulation, and (c) not a person or entity with whom a U.S. person is prohibited from conducting business under the OFAC Rules.
20. Counterparts. This Agreement may be executed in 2 or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature process complying with the U.S. federal ESIGN Act of 2000) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. Electronic signatures shall be deemed original signatures for purposes of this Agreement and all matters related thereto, with such electronic signatures having the same legal effect as original signatures.
[Signatures are on the next page]
5 |
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
TENANT: | ||||
ATRECA, INC., | ||||
a Delaware corporation | ||||
By: | /s/ Xxxx Xxxxx | |||
Its: | CFO | |||
x I hereby certify that the signature, name, | ||||
and title above are my signature, name and title | ||||
LANDLORD: | ||||
ARE-SAN FRANCISCO NO. 63, LLC, | ||||
a Delaware limited liability company | ||||
By: | Alexandria Real Estate Equities, L.P., | |||
a Delaware limited partnership, | ||||
managing member | ||||
By: | ARE-QRS Corp., | |||
a Maryland corporation, | ||||
general partner | ||||
By: | Xxxxxxx Xxxxxx | |||
Its: | Vice President - Real Estate |
6 |
Exhibit A
Bill of Sale and Assignment
THIS BILL OF SALE AND ASSIGNMENT (“Bill of Sale”) is made as of September 20, 2023, by ATRECA, INC., a Delaware corporation (“Tenant”), to ARE-SAN FRANCISCO NO. 63, LLC, a Delaware limited liability company (“Landlord”).
RECITALS
X. Xxxxxxxx and Tenant are now parties to that certain Lease Agreement dated as of July 17, 2019, as affected by that certain letter agreement dated as of August 24, 2020 (as amended, the “Lease”). Pursuant to the Lease, Tenant leases approximately 99,557 rentable square feet (the “Premises”) in that certain building located at 000 Xxxxxxxxxx Xxxx, Xxx Xxxxxx, Xxxxxxxxxx, as more particularly described in the Lease. Capitalized terms used herein without definition shall have the meanings defined for such terms in the Lease.
X. Xxxxxxxx and Xxxxxx have entered into that certain Agreement for Modification of Lease and Voluntary Surrender of Premises on or about the date hereof (the “Modification Agreement”). The Modification Agreement requires Tenant to convey to Landlord all of Tenant’s right, title and interest in, to and under the Personal Property (as defined below) located in the Premises in connection with Xxxxxx’s surrender of the Premises.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Xxxxxx hereby agrees as follows:
1. | Unless the context otherwise requires, all capitalized terms used but not otherwise defined herein shall have the respective meanings provided therefor in the Lease. |
2. | Tenant does hereby unconditionally, absolutely, and irrevocably grant, bargain, sell, transfer, assign, convey, set over and deliver unto Landlord on the Termination Date (as defined in the Modification Agreement) all of Tenant’s right, title and interest in and to all furniture, fixtures and equipment located within the Premises owned by Tenant as more particularly described on Schedule 1 attached hereto (collectively, the “Personal Property”). Tenant shall provide Landlord with the date(s) that Tenant acquired the Personal Property and the purchase price(s) paid by Tenant for the Personal Property. |
3. | Tenant represents and warrants that its title to the Personal Property is free and clear of all liens, mortgages, pledges, security interests, prior assignments, encumbrances and claims of any nature. |
4. | The conveyance herein shall be on an “AS-IS, WHERE-IS” basis without representation or warranty of any kind except as expressly set forth herein or in the Modification Agreement. |
5. | This Bill of Sale shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns. |
6. | This Bill of Sale and the legal relations of the parties hereto shall be governed by and construed and enforced in accordance with the internal laws of the state in which the Premises are located, excluding any principles of conflicts of laws. |
7. | Tenant represents and warrants as of the date hereof that the individual signing this Bill of Sale on behalf of Tenant is authorized to do so. |
A-1
IN WITNESS WHEREOF, this Bill of Sale was made and executed as of the date first above written.
TENANT: | ATRECA, INC., a Delaware corporation |
By: | /s/ Xxxx Xxxxx | |
Name: | Xxxx Xxxxx | |
Its: | CFO | |
x I hereby certify
that the signature, name, and title above are my signature, name and title |
A-2
Schedule 1
Personal Property
Floor | Current Room | Room Name | Client Asset # | Item Name/ Description | MFR | Make and Model No. | Serial |
3rd | 3061 | MB RT | LE28 | Scepter Automated Cell Counter | Millipore | Scepter 2.0 Automated Cell Counter | |
3rd | 3061 | MB RT | Nikon Eclipse TS100 Microscope | Nikon | C001315B | ||
3rd | 3061 | MB RT | LE131 | Nikon Eclipse TS100 Microscope | Nikon | ||
3rd | 3061 | MB RT | LE74 | Edgertronic High Speed Camera | Edgertronic | ||
3rd | 3061 | MB RT | LE109 | PLATE INCUBATOR | Thermo Xxxxxx | HERAtherm IMH180-S | 41665974 |
3rd | 3062 | Reagent Prep | -- | Analytical Balance, Max. 200g | Xxxxxx-Xxxxxx | AS220.R2 | 422439 |
3rd | 3062 | Reagent Prep | LE60 | Plate Sealer | Axygen | PlateMax | LAHSAXY-1301009 |
3rd | 3062 | Reagent Prep | -- | Micro Balance | Ohaus | SPX2202 | B918598367 |
4th | 4059 | ProtEng Yeast | LE122 | Nikon Eclipse TS100 microscope | Nikon | Eclipse TS100 | |
4th | 4062 | MB SELECTION | LE97 | FACS SORTER (BD FACSJazz) | BD | BD FACS-Jazz | JZ6554900050 |
4th | 4066 | MICROSCOPY | NA | Zeiss | Axio Scan.Z1 | 4631001065 | |
4th | 4066 | MICROSCOPY | LE369 | Pannoramic Scan | 3dHISTECH | Pannoramic Scan 2 | |
4th | 4066 | MICROSCOPE | LE189 | PO 3104-Nikon Nie Microscope system plus. | Nikon | Ni-E | |
4th | 4066 | MICROSCOPE | NA | Microscope system plus. | Nikon | DS-Ri2 | |
4th | 4074 | ProtEng Upstream | LE100 | PO 1484 Trinocular Microscope | Nikon | Nikon Eclipse TS100 | 151093 |
4th | 4075 | Tissue Culture | TOTAL 2 | Microscope | NIKON | Eclipse TS2 and one TS2R | |
4th | 4080 | invitro | LE350 | PO 10002 gentleMACS Octo Dissociator w/heaters | Miltenyi Biotec | gentleMACS Octo Dissociator with heaters | |
4th | 4080 | invitro | Microscope eclipse | Nikon | TS2 | ||
4th | 4081 | ProtEng Downstream | LE349 | PO 10156 Azure C200 Imaging System | Azure | Azure C200 | 2101 |
4th | 4082 | Epitope ID | LE283 | PO 6509 AKTA Pure L | Cytiva | AKTA Pure | |
4th | 4082 | Epitope ID | LE455 | AKTA Sample pump | AKTA | Sample pump S9 | |
4th | 4082 | Epitope ID | LE380 | FPLC - NGC Quest™ 100 Plus Chromatography System + Comp | Bio-Rad | Bio-Rad NGC Quest™ 100 System, 7880004 | center bench |
4th | 4082 | Epitope ID | LE387 | FPLC - autosampler | Teledyne CETAC | ASX-560 BIO-RAD | center bench w/NGC |
4th | 4082 | Epitope ID | LE 374,5,6,7,8 & 436 | HPLC + Autosampler + Comp - Agilent (black and white one) | Agilent | 1260 Infinity II | center bench under beam |
3rd | 3060A | CB Facs TC | LE52 | Eclipse TS100 microscope / camera / PC | Xxxxx | Xxxxx, TS100/Amazon | |
3rd | 3059 | Clean Corridor | LE98 | Hoshizaki F-801MWH Ice flaker | Hoshizaki | F-801MWH | D11242F |
3rd | 3060 | CB Facs Core | NA | 4 DEG | Kenmore | Kenmore- Fridge | |
3rd | 3060 | CB Facs Core | NA | -20 DEG | Frigidaire | Frigidaire | |
3rd | 3060 | CB Facs Core | LE97 | 4' BSC 11-A2 (no UV) | Xxxxx | Xxxxx | |
3rd | 3060 | CB Facs Core | NA | FLAM CAB/large | NA | ||
3rd | 3060 | CB Facs Core | LE114 | 4' BSC 11-A2 | Xxxxx | Xxxxx | |
3rd | 3061 | MB RT | ATRC0880 | 4 DEG Refrigerator | Kenmore | -- | WA44503170 |
3rd | 3061 | MB RT | -- | 4C Refrigerator, BIRC Supplies | Danby Products | Danby Designer | 11409010050 |
3rd | 3061 | MB RT | LE126 | BSC: PO 1920 - SG504 Biosafety Cabinet | Xxxxx | SterilGARD SG 504 | 114055 |
3rd | 3061 | MB RT | LE16 | BSC: SG503A-HE w/FlexAIR | Xxxxx | SterilGARD SG503A-HE | 107537 |
3rd | 3061 | MB RT | LE132 | 5' CLASS 11A (Esco Master Mix hood) | ESCO | -- | -- |
A-3
3rd | 3061 | MB RT | -- | Portable bench | 72X30 | ||
3rd | 3061 | MB RT | -- | Portable bench | 60X30 | ||
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 60X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 60X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 60X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 60X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 60X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | 48X30 | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | -- | -- | -- |
3rd | 3061 | MB RT | -- | Lab (Island) Bench, 48inx30in modular Unit | -- | -- | -- |
3rd | 3062 | MB RT | LE183 | 5' CLASS 11A (Esco Master Mix hood) | ESCO | -- | -- |
3rd | 3062 | Reagent Prep | -- | -20 DEG Freezer | Kenmore | -- | -- |
3rd | 3062 | Reagent Prep | -- | 4 DEG Refrigerator | Kenmore | -- | -- |
3rd | 3062 | Reagent Prep | -- | Build-in flammable cabinet | |||
3rd | 3062 | Reagent Prep | -- | build-in chemical cabinet | |||
3rd | 3064 | Cryo Frz | LE19 | -80 Freezer #1 | Panasonic | MDF-U76VA | 12077N0043 |
3rd | 3064 | Cryo Frz | -- | Lab Bench, 5ft, w/ shelf | -- | -- | -- |
3rd | 3064 | Cryo Frz | LE76 | -80 Freezer #2 | Panasonic | MDF-U76VA | 15107N0260 |
3rd | 3064 | Cryo Frz | -- | Lab Bench, 4ft, w/ shelf | -- | -- | -- |
3rd | 3064 | Cryo Frz | -- | Lab Table, 4ft | |||
3rd | 3064 | Cryo Frz | LE455 | LN2 xxxxx | |||
3rd | 3068 | Cryo Frz | LE255 | LN2 Sample CryoStorage Unit | Worthington | 24K-CS200 | 30876 |
3rd | 3071 | Lab bench 4ft x 3ft | |||||
3rd | 3073 | LE401 | BSC | Xxxxx | Steril Gard | ||
3rd | 3073 | LE400 | BSC | Xxxxx | Steril Gard | ||
3rd | 3073 | 6ft portable lab bench with shelves | |||||
3rd | 3076 | MB Post Amp | N/A | -20 DEG Freezer | Kenmore | -- | -- |
3rd | 3076 | MB Post Amp | N/A | -20 DEG Freezer | Kenmore | -- | -- |
3rd | 3076 | MB Post Amp | N/A | -20 DEG Freezer | Xxxxxx | -- | -- |
3rd | 3076 | MB Post Amp | N/A | -20 DEG Freezer | Xxxxxx | -- | -- |
3rd | 3076 | MB Post Amp | N/A | Skinny Freezer -20C | |||
3rd | 3076 | MB Post Amp | N/A | Skinny Fridge 4C | |||
3rd | 3076 | MB Post Amp | N/A | Small -20 Freezer | |||
3rd | 3076 | MB Post Amp | Fume Hood | ||||
3rd | 3080 | TS SOLV | QTY 2 | FLAM CAB | |||
3rd | 3081 | Rad Lab - Hot | ATRC 0781 | 4' BSC - Class II B2 | Xxxxx Company | BioChemGard; BCG401 | 137304 |
3rd | 3081 | Rad Lab - Hot | ATRC 0757 | 4ft BSC- class 2 | Xxxxx Company | SterilGard III Advance; Model: SG 403 | 69151 |
3rd | 3082 | LE276 | Panasonic -80C (Mouse tissues) | ||||
3rd | 3083 | TM-MB ASSAY LAB | DD DELI | Xxxxxx | Xxxxxx Isotemp GTFBG45CPLA | 300404420 | |
3rd | 3083 | TM-MB ASSAY LAB | -20 Freezer | American Biotech Supply | ABT-HC-MFP-20 | ABS-21056829-2111 | |
3rd | 3083 | TM-MB ASSAY LAB | -80 Freezer | Thermo Xxxxxx Scientific | Thermo Xxxxxx Scientific TSX Series TSX60086A | 1124365701211023 | |
3rd | 3084 | ATRC0918 | DD DELI | ||||
3rd | 3084 | ATRC0917 | DD DELI | ||||
3rd | 3084 | NA | Combo freezer/fridge | kenmore | |||
3rd | 3084 | NA | Combo freezer/fridge | kenmore | |||
3rd | 3084 | Trans Sci | NA | Accucold Pharmaceutical Storage 4 degree | Accucold | ||
4th | 4059 | ProtEng Yeast | LE306 | MPR-715F combo Lab fridge/freezer | PHCBI | MPR-715F Combo | 18039030 |
4th | 4059 | ProtEng Yeast | LE416 | 4' BSC | Esco | Labculture Reliant Gen 2E Class II Type A2 BSC | 2020-150474 |
4th | 4059 | ProtEng Yeast | LE453 | 4C Deli Fridge | PHCBI | MPR-1412-PA | 21010005 |
4th | 4061 | MB HELPER | ATRC 0922 | 4 DEG/-20 DEG | Panasonic | ||
4th | 4062 | MB SELECTION | LE267 | 4 DEG/-20 DEG | |||
4th | 4062 | MB SELECTION | N/A | Ice Maker | |||
4th | 4064 | GLASSWASH | LE18 | Ice Maker | Hoshizaki | F-330BAH Cubelet Ice Maker | |
4th | 4064 | GLASSWASH | BROKEN | Autoclave | Steris | ||
4th | 4067 | E coli | NA | Lab Table | |||
4th | 4067 | E coli | NA | Lab Table | |||
4th | 4068 | Media Prep | LE268 | Milli-Q Integral 15 system | Millipore | MiiliQ Integral 15 System |
A-4
3rd | 4071 | outside of Upstream | LE262 | Panasonic Narrower -80 freezer | Panasonic | MDF-U33V-PA Ultra Low Temp Freezer | |
4th | 4074 | ProtEng Upstream | LE391 | Deli Fridge double doors | PHCbi | ||
4th | 4074 | ProtEng Upstream | LE237 | PO 4655 Class II Type A2 BSC | NuAire | NU-543-400 Nuaire | 176565101216 |
4th | 4074 | ProtEng Upstream | LE307 | 4' BSC II-A2 | ESCO | Class II BSC AC2-4s9 | 2018-125621 |
4th | 4074 | ProtEng Upstream | NA | -20 DEG | Kenmore | white-box type | WB23250682 |
4th | 4074 | ProtEng Upstream | NA | 4 DEG | Kenmore | white-box type | WA40602545 |
4th | 4074 | ProtEng Upstream | LE364 | 6' CLASS IIA | ESCO | LA2-6A2-E-PORT | 2019-140072 |
4th | 4074 | ProtEng Upstream | LE448 | 4' BSC II-A2 #2 | XXXX | XXXX LA2-4A2-E-PORT-AF | 2020-158843 |
4th | 4074 | ProtEng Upstream | LE451 | 6' BSC II-A2 #2 | XXXX | XXXX LA2-6A2-E-PORT-AF | 2020-159883 |
4th | 4074 | ProtEng Upstream | LE269 | Pharmaceutical Refrigerator | Panasonic | MPR-721-PA | 17020067 |
4th | 4075 | Tissue Culture | 4 DEG | Kenmore | 253.6072201 | ||
4th | 4075 | Tissue Culture | 4 DEG | Kenmore | 253.6072201 | ||
4th | 4075 | Tissue Culture | -20 DEG | Kenmore | 253.2104241 | ||
4th | 4075 | Tissue Culture | LE333 | 4' TYPE II-A2 BSC | XXXXX | ||
4th | 4075 | Tissue Culture | Xxxxx SterilGARD eIII (4ft) | XXXXX | |||
4th | 4075 | Tissue Culture | LE460 | 4' TYPE II-A2 BSC | XXXXX | ||
4th | 4075 | Tissue Culture | LE462 | 4' TYPE II-A2 BSC | XXXXX | ||
4th | 4076 | Corridor | -20 DEG AT043686 | Kenmore | 253.2104241 | ||
4th | 4076 | Corridor | LE329 | -80 DEG Freezer ("Clinical") AT019126 | ThermoScientific | TSX60086A | 1119686801190120 |
4th | 4076 | Corridor | LE343 | -80 DEG Freezer AT043687 | ThermoScientific | TSX60086A | |
4th | 4077 | SHARED TC | -20 Freezer Xxxxx | Xxxxxxx | |||
4th | 4078 | Ab Inventory | no tag | PO 31274 Danby Designer 4.4 Cubic Feet Compact Refrigerator | |||
4th | 4079 | Target ID | Deli Fridge #1 | PHCBI | MPR-1412-PA | 19040042 | |
4th | 4079 | Target ID | LE347 | Deli Fridge #5 | PHCBI | ||
4th | 4079 | Target ID | -20C Freezer | Kenmore | WB45127105 | ||
4th | 4079 | Target ID | -20C Freezer | Frigidaire | WB91563159 | ||
4th | 4080 | Ab Inventory | LE447 | 4' BSC | XXXX | XXXX LA2-4A2-E-PORT-AF | 2020-158842 |
4th | 4080 | invitro | LE337 | Panasonic double door deli xxxxxx | Xxxxxxxxx | MPR-1411-PA | |
4th | 4080 | invitro | Panasonic double door deli xxxxxx | Xxxxxxxxx | MPR-1411-PA | ||
4th | 4080 | invitro | 4 DEG Fridge (this was shared between Target ID and Trans Sci) | Kenmore | 253.6072201 | ||
4th | 4080 | invitro | -20 DEG Freezer | Kenmore | 253.2104241 | ||
4th | 4081 | ProtEng Downstream | LE310 | -80 DEG | Panasonic | MDF-U76VA-PA | 17087No274 |
4th | 4081 | ProtEng Downstream | LE113 | -20 DEG | Kenmore | Kenmore 21 cu ft | |
4th | 4081 | ProtEng Downstream | LE359 | DD DELI | PHCBI | MPR-1412-PA | 19040044 |
4th | 4081 | ProtEng Downstream | LE286 | 4' BSC | Nuair | 4' | 1.18639E+11 |
4th | 4081 | ProtEng Downstream | N/A | PO 14591 DD DELI | PHCBI | MPR-1412-PA | |
4th | 4081 | ProtEng Downstream | LE486 | Water filter: Sartorius arium comfort | Sartorius | arium comfort | |
4th | 4082 | Epitope ID | LE273 | double door deli fridge | Panasonic | along wall w/Akta inside | |
4th | 4082 | Epitope ID | LE469 | Combo 4C fridge and -30C freezer | PHC | MPR-715F-PA | |
4th | 4082 | Epitope ID | LE470 | Freezer -80C | PHC | MDF-U76VA-PA | |
3rd | 3060A | CB Facs TC | LE07 | 4' BSC | Xxxxx | Xxxxx, SteriGARD 404 | |
3rd | 3060A | CB Facs TC | LE250 | 6' BSC CLASS 11A | Xxxxx | Xxxxx | |
3rd | 3060A | CB Facs TC | 878 | 4 DEG | Whirlpool | Wrhirlpool - Fridge | |
3rd | 3060A | CB Facs TC | NA | -20 DEG (small) | Kenmore | Kenmore | |
3rd | 3060A | CB Facs TC | LE216 | Lab Bench | |||
3rd | 3061A | MB RT | -- | -20 DEG Freezer | Kenmore | -- | -- |
3rd | 3061A | MB RT | -- | -20 DEG Freezer | Kenmore | -- | -- |
3rd | 3061A | MB RT | -- | -20 DEG for cDNA/RT plate storage (IRC) | Kenmore | 255.2970201 | BLR2127118920286 |
3rd | 3084A | Epitope ID | LE449 | 4' BSC | ESCO LA2-4A2-E-PORT-AF | 2020-158844 | |
3rd | 3084A | Trans Sci | ATRC 0964 | Black freezer/fridge combo | Kenmore |
A-5
3rd | 3084A | Trans Sci | ATRC 0957 | White freezer/fridge combo | kenmore | ||
3rd | 3084A | Trans Sci | LE488 | Arium advance | Sartorius | (needs new tank) | |
3rd | 3068 | Utility Room | LN2 distribution manifold | Concoa | 5771113-01-100 | 20C16RPT | |
3rd | 3068 | Utility Room | CO2 distribution manifold | Praxair | Prospec PRS9000 | ||
3rd | 3068 | Utility Room | Compressed air system with pressure vessel and air dryer | Atlas Copco | ZT 15 | API796795 | |
3rd | 3068 | Utility Room | House vacuum system | Atlas Copco | GVS 300A | 36940 | |
3rd | 3068 | Utility Room | Nitrogen charged pre-action fire suppression system | South-Tek Systems | Fireflex N2-Blast | ||
3rd & 4th | N/A | Office workstations - approximatley 151 | |||||
3rd & 4th | N/A | Office chairs - approximatley 465 | |||||
3rd & 4th | N/A | Lab benches - approximatley X | |||||
3rd & 4th | Furniture in conference rooms - approximately 23 | ||||||
3rd & 4th | N/A | Whiteboards - approximatley 67 | |||||
3rd & 4th | TVs - approximatley 30 | ||||||
3rd & 4th | N/A | Miscelanous office furniutre in soft seating and collaboration areas | |||||
3rd & 4th | Lab charis - approximatley 160 | ||||||
3rd & 4th | 4084 | Lab workstations/benches - approximatley 260 | |||||
4th | 4084 | All shades @ exterior perimeter windows | |||||
3rd | 3086 | All shades @ exterior perimeter windows | |||||
4th | N/A | Hoshizaki F-330BAH Ice flaker w/H9320-1 filter | |||||
3rd | N/A | Hoshizaki Modular Air-cooled Ice xxxxx | |||||
4th | N/A | Ice Machine (Hoshizaki lab grade) | |||||
3rd | 3068 | Freezer Ultra Low Temp | Stirling | ||||
3rd & 4th | All conference room AV equipment | ||||||
3rd & 4th | Wireless Meraki Access Points - installed | ||||||
3rd & 4th | Monitor arms and port replicators | ||||||
3rd & 4th | Monitors attached to monitor arms | ||||||
3rd & 4th | Polycoms in conf rooms | ||||||
3rd | 3060 | CB Facs Core | LE81 | micro-centrifuge | Eppendorf | Eppendorf, 5418 | |
4th | 4059 | ProtEng Yeast | NA | Static non-CO2 incubator | VWR | 89511-418 (Grav Conv 2.6 CF) Type Code: 51030015 | 42335717 |
4th | 4081 | ProtEng Downstream | iBind | Invitrogen | |||
4th | 4081 | ProtEng Downstream | iBindFlex | Invitrogen | |||
3rd | 3083A | TM-MB ASSAY LAB | Digital Microscope Slide Scanner | Leica | Aperio AT2 | 7838 |
A-6